Maccabi Healthcare Services: Israel's Digital-First Health Fund

Maccabi Healthcare Services (Hebrew: Maccabi Sherutei Bri'ut) is the second-largest of Israel's four statutory health funds, covering approximately 2.6 million members — roughly a quarter of the Israeli population. Maccabi is licensed under the 1995 National Health Insurance Law and is widely considered the technology-forward and data-forward fund in the Israeli payer system. Its research arm, the KSM Research Institute (Kahn-Sagol-Maccabi), is one of the most-cited longitudinal medical-data platforms in global academic health research.

Founding and historical positioning

Maccabi was founded in 1940 in pre-state Mandate-era Tel Aviv as an alternative to the then-Histadrut-affiliated Klalit. The founding cohort was drawn from the urban middle class and the professional and merchant classes of the Yishuv — populations that were not comfortable with the Histadrut's socialist orientation and sought a health fund with a more independent, professional identity. That founding demographic pattern has echoed through the decades: Maccabi's membership base has historically skewed urban, middle- and upper-middle class, and concentrated in Tel Aviv, Jerusalem, and the coastal center of the country.

The 1995 National Health Insurance Law universalized coverage and removed the historical class-and-labor stratification between the Kupot Holim. Maccabi's growth since then has come from converts from Klalit — members switching in during the annual open-enrollment window — driven by Maccabi's reputation for shorter clinic wait times, better digital service, and stronger primary-care relationships. Membership has grown roughly 40 percent since 1995, faster than the Israeli population.

Operating model

Maccabi does not own a hospital network. The fund contracts inpatient and specialist care from Assuta Medical Centers (which Maccabi part-owns), Hadassah, Sheba, Ichilov (Sourasky), Rambam, and other independent providers. Its operating advantage is concentrated in three areas: primary care, digital health, and one of the most-cited longitudinal medical-data assets in academic health research.

Primary care

Maccabi runs approximately 220 community clinics, most of them mid-sized multi-specialty centers rather than the small neighborhood clinics that characterize Klalit's periphery footprint. Maccabi's primary-care model emphasizes physician continuity — members are formally attached to a personal family physician — and short referral loops between primary care and specialty medicine.

Digital health

Maccabi's electronic medical record system is the most widely cited in international health-services literature as an early and successful rollout of integrated payer-provider EHR. The member-facing app allows appointment booking, prescription renewal, lab results, referral (Tofes 17) requests, and telemedicine consultations. Maccabi was the first Israeli Kupah to offer telemedicine at scale and continues to lead the four funds in remote-consultation volume.

KSM Research Institute

The KSM Research Institute (Kahn-Sagol-Maccabi) is the research arm that manages Maccabi's anonymized longitudinal member-data platform. KSM has powered peer-reviewed publications on COVID-19 vaccine efficacy (Maccabi produced some of the earliest real-world effectiveness data on the mRNA vaccines during 2020–2021), chronic-disease progression, cardiovascular outcomes, and population-health interventions. KSM is one of the most-cited real-world-evidence platforms in academic literature — comparable to the Kaiser Permanente or UK Biobank datasets, at a fraction of the size but with the advantage of complete lifetime member records under a universal-coverage regime.

Position in the Israeli payer system

Maccabi's data infrastructure has made it a primary research and validation partner for Israeli health-tech firms and multinational pharmaceutical companies running real-world-evidence studies in Israel. The fund's clinical-trial relationships extend into innovation arms such as Sheba ARC, Assuta Innovation, and the technology-transfer arms of Israel's research universities. Multinational pharma companies frequently structure Israeli phase-IV studies through Maccabi because the data quality and speed of member-recruitment are unusually favorable.

Among the four statutory funds, Maccabi is most often cited in international health-services literature for the maturity of its electronic medical record system and its early adoption of digital-first member services. Health-system planners in the United States, the United Kingdom, and Northern Europe have visited Maccabi to study the primary-care-plus-digital model as a template for integrated ambulatory care.

Service entitlements are defined annually by the Sal HaTziyud and accessed through the Tofes 17 referral commitment.

Governance and funding

Maccabi is governed by a board that operates without the elected-assembly structure Klalit inherited from its Histadrut origins. Funding comes from statutory capitation transfers via Bituach Leumi, member co-payments, supplemental insurance premiums (Maccabi Sheli, Maccabi Zahav, Maccabi Shelli Platinum), and independent contracted revenue. Roughly 90 percent of Maccabi members carry supplemental insurance — the highest attach rate of the four Kupot Holim, reflecting the middle-class income profile of the membership base.

Why it matters

Maccabi is the innovation-facing member of the four-Kupah system. Its scale is smaller than Klalit's, its periphery footprint is thinner, its hospital exposure is contracted rather than owned. What it has instead is data, digital infrastructure, and a member base concentrated in Israel's economic and technological center of gravity. Every serious Israeli health-tech company works with Maccabi in some capacity — as a validation partner, a data provider, or a first customer. Maccabi is the payer that made itself the platform.

One in four Israelis is a Maccabi member. The number grows every year. That is what data-forward looks like at national scale.